What makes LINA (Lipid Intervention, possibly a genetic or therapeutic factor) resistant to atherosclerosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 3, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the clinical utility of Apo (Apolipoprotein) E testing and NMR (Nuclear Magnetic Resonance) lipid profiling in assessing cardiovascular disease risk?

What is the relationship between cholesterol metabolism and the development of atherosclerosis?

How should I interpret a lipid panel and decide on therapy based on the patient's cardiovascular risk?

What is the interpretation of a lipid panel showing hypercholesterolemia (Total Cholesterol 300 mg/dL), hypertriglyceridemia (Triglycerides 205 mg/dL), normal High-Density Lipoprotein (HDL) Cholesterol (51 mg/dL), normal Very-Low-Density Lipoprotein (VLDL) Cholesterol (40 mg/dL), and hyperlipidemia with elevated Low-Density Lipoprotein (LDL) Cholesterol (209 mg/dL)?

Is saturated fat a major contributor to atherosclerotic heart disease?

What is the best approach to gather a comprehensive cardiac history for a patient with potential heart conditions, considering their demographic information, medical history, symptoms, laboratory results, and current medications?

What are the maximum BiPAP (Bilevel Positive Airway Pressure) settings for an adult patient with respiratory issues such as Chronic Obstructive Pulmonary Disease (COPD) or sleep apnea?

What are the risks of antibiotic resistance in a patient with a history of respiratory issues and recent trauma, treated with parenteral cefixime (cephalosporin antibiotic) for 2 days?

What is the immediate management for a patient with sepsis of urinary origin?

Why is the Left Internal Mammary Artery (LIMA) resistant to atherosclerosis?

What is the best approach to manage acute CO2 retention, particularly in a patient with chronic obstructive pulmonary disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.